Cargando…

Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial

BACKGROUND AND AIM: Iron deficiency is associated with increased morbidity and mortality in older adults. However, data on its prevalence and incidence among older adults is limited. The aim of this study was to investigate the prevalence and incidence of iron deficiency in European community-dwelli...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahl-Gugger, Alenka, de Godoi Rezende Costa Molino, Caroline, Wieczorek, Maud, Chocano-Bedoya, Patricia O., Abderhalden, Lauren A., Schaer, Dominik J., Spahn, Donat R., Orav, E. John, Vellas, Bruno, da Silva, José A. P., Kressig, Reto W., Egli, Andreas, Bischoff-Ferrari, Heike A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464157/
https://www.ncbi.nlm.nih.gov/pubmed/35304704
http://dx.doi.org/10.1007/s40520-022-02093-0
_version_ 1784787521035567104
author Stahl-Gugger, Alenka
de Godoi Rezende Costa Molino, Caroline
Wieczorek, Maud
Chocano-Bedoya, Patricia O.
Abderhalden, Lauren A.
Schaer, Dominik J.
Spahn, Donat R.
Orav, E. John
Vellas, Bruno
da Silva, José A. P.
Kressig, Reto W.
Egli, Andreas
Bischoff-Ferrari, Heike A.
author_facet Stahl-Gugger, Alenka
de Godoi Rezende Costa Molino, Caroline
Wieczorek, Maud
Chocano-Bedoya, Patricia O.
Abderhalden, Lauren A.
Schaer, Dominik J.
Spahn, Donat R.
Orav, E. John
Vellas, Bruno
da Silva, José A. P.
Kressig, Reto W.
Egli, Andreas
Bischoff-Ferrari, Heike A.
author_sort Stahl-Gugger, Alenka
collection PubMed
description BACKGROUND AND AIM: Iron deficiency is associated with increased morbidity and mortality in older adults. However, data on its prevalence and incidence among older adults is limited. The aim of this study was to investigate the prevalence and incidence of iron deficiency in European community-dwelling older adults aged ≥ 70 years. METHODS: Secondary analysis of the DO-HEALTH trial, a 3-year clinical trial including 2157 community-dwelling adults aged ≥ 70 years from Austria, France, Germany, Portugal and Switzerland. Iron deficiency was defined as soluble transferrin receptor (sTfR) > 28.1 nmol/L. Prevalence and incidence rate (IR) of iron deficiency per 100 person-years were examined overall and stratified by sex, age group, and country. Sensitivity analysis for three commonly used definitions of iron deficiency (ferritin < 45 μg/L, ferritin < 30 μg/L, and sTfR–ferritin index > 1.5) were also performed. RESULTS: Out of 2157 participants, 2141 had sTfR measured at baseline (mean age 74.9 years; 61.5% women). The prevalence of iron deficiency at baseline was 26.8%, and did not differ by sex, but by age (35.6% in age group ≥ 80, 29.3% in age group 75–79, 23.2% in age group 70–74); P < 0.0001) and country (P = 0.02), with the highest prevalence in Portugal (34.5%) and the lowest in France (24.4%). As for the other definitions of iron deficiency, the prevalence ranged from 4.2% for ferritin < 30 µg/L to 35.3% for sTfR–ferritin index > 1.5. Occurrences of iron deficiency were observed with IR per 100 person-years of 9.2 (95% CI 8.3–10.1) and did not significantly differ by sex or age group. The highest IR per 100 person-years was observed in Austria (20.8, 95% CI 16.1–26.9), the lowest in Germany (6.1, 95% CI 4.7–8.0). Regarding the other definitions of iron deficiency, the IR per 100 person-years was 4.5 (95% CI 4.0–4.9) for ferritin < 45 µg/L, 2.4 (95% CI 2.2–2.7) for ferritin < 30 µg/L, and 12.2 (95% CI 11.0–13.5) for sTfR–ferritin index > 1.5. CONCLUSIONS: Iron deficiency is frequent among relatively healthy European older adults, with people aged ≥ 80 years and residence in Austria and Portugal associated with the highest risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40520-022-02093-0.
format Online
Article
Text
id pubmed-9464157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-94641572022-09-12 Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial Stahl-Gugger, Alenka de Godoi Rezende Costa Molino, Caroline Wieczorek, Maud Chocano-Bedoya, Patricia O. Abderhalden, Lauren A. Schaer, Dominik J. Spahn, Donat R. Orav, E. John Vellas, Bruno da Silva, José A. P. Kressig, Reto W. Egli, Andreas Bischoff-Ferrari, Heike A. Aging Clin Exp Res Original Article BACKGROUND AND AIM: Iron deficiency is associated with increased morbidity and mortality in older adults. However, data on its prevalence and incidence among older adults is limited. The aim of this study was to investigate the prevalence and incidence of iron deficiency in European community-dwelling older adults aged ≥ 70 years. METHODS: Secondary analysis of the DO-HEALTH trial, a 3-year clinical trial including 2157 community-dwelling adults aged ≥ 70 years from Austria, France, Germany, Portugal and Switzerland. Iron deficiency was defined as soluble transferrin receptor (sTfR) > 28.1 nmol/L. Prevalence and incidence rate (IR) of iron deficiency per 100 person-years were examined overall and stratified by sex, age group, and country. Sensitivity analysis for three commonly used definitions of iron deficiency (ferritin < 45 μg/L, ferritin < 30 μg/L, and sTfR–ferritin index > 1.5) were also performed. RESULTS: Out of 2157 participants, 2141 had sTfR measured at baseline (mean age 74.9 years; 61.5% women). The prevalence of iron deficiency at baseline was 26.8%, and did not differ by sex, but by age (35.6% in age group ≥ 80, 29.3% in age group 75–79, 23.2% in age group 70–74); P < 0.0001) and country (P = 0.02), with the highest prevalence in Portugal (34.5%) and the lowest in France (24.4%). As for the other definitions of iron deficiency, the prevalence ranged from 4.2% for ferritin < 30 µg/L to 35.3% for sTfR–ferritin index > 1.5. Occurrences of iron deficiency were observed with IR per 100 person-years of 9.2 (95% CI 8.3–10.1) and did not significantly differ by sex or age group. The highest IR per 100 person-years was observed in Austria (20.8, 95% CI 16.1–26.9), the lowest in Germany (6.1, 95% CI 4.7–8.0). Regarding the other definitions of iron deficiency, the IR per 100 person-years was 4.5 (95% CI 4.0–4.9) for ferritin < 45 µg/L, 2.4 (95% CI 2.2–2.7) for ferritin < 30 µg/L, and 12.2 (95% CI 11.0–13.5) for sTfR–ferritin index > 1.5. CONCLUSIONS: Iron deficiency is frequent among relatively healthy European older adults, with people aged ≥ 80 years and residence in Austria and Portugal associated with the highest risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40520-022-02093-0. Springer International Publishing 2022-03-18 2022 /pmc/articles/PMC9464157/ /pubmed/35304704 http://dx.doi.org/10.1007/s40520-022-02093-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Stahl-Gugger, Alenka
de Godoi Rezende Costa Molino, Caroline
Wieczorek, Maud
Chocano-Bedoya, Patricia O.
Abderhalden, Lauren A.
Schaer, Dominik J.
Spahn, Donat R.
Orav, E. John
Vellas, Bruno
da Silva, José A. P.
Kressig, Reto W.
Egli, Andreas
Bischoff-Ferrari, Heike A.
Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial
title Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial
title_full Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial
title_fullStr Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial
title_full_unstemmed Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial
title_short Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial
title_sort prevalence and incidence of iron deficiency in european community-dwelling older adults: an observational analysis of the do-health trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464157/
https://www.ncbi.nlm.nih.gov/pubmed/35304704
http://dx.doi.org/10.1007/s40520-022-02093-0
work_keys_str_mv AT stahlguggeralenka prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT degodoirezendecostamolinocaroline prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT wieczorekmaud prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT chocanobedoyapatriciao prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT abderhaldenlaurena prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT schaerdominikj prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT spahndonatr prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT oravejohn prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT vellasbruno prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT dasilvajoseap prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT kressigretow prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT egliandreas prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT bischoffferrariheikea prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial
AT prevalenceandincidenceofirondeficiencyineuropeancommunitydwellingolderadultsanobservationalanalysisofthedohealthtrial